Corbus Pharmaceuticals Holdings, Inc.
CRBP
$8.24
-$0.07-0.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -146.09% | -18.80% | -37.10% | -13.81% | 61.12% |
| Total Depreciation and Amortization | -46.71% | -9.46% | -0.65% | -4.93% | -16.44% |
| Total Amortization of Deferred Charges | -- | -100.00% | -62.75% | -42.20% | -6.51% |
| Total Other Non-Cash Items | 1,792.31% | 46.14% | 138.17% | -62.05% | -90.52% |
| Change in Net Operating Assets | 32.71% | -357.84% | -210.76% | 426.59% | -204.38% |
| Cash from Operations | -106.11% | -82.12% | -94.29% | -14.63% | 47.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 118.45% | -15.96% | -241.00% | -286.66% | -1,870.11% |
| Cash from Investing | 118.45% | -15.96% | -241.00% | -286.66% | -1,870.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -1,370.58% | -1,391.90% | -1,443.64% |
| Issuance of Common Stock | -- | -- | -- | 17,875.28% | 293,428.30% |
| Repurchase of Common Stock | -- | 82.43% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 99.32% | 3,150.43% | 194,147.22% | 94,420.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 349.08% | -189.90% | -247.00% | 835.53% | 103.92% |